Quantcast

Latest Paracetamol Stories

2014-09-16 12:31:25

SAN FRANCISCO, Sept. 16, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK((TM)) (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief...

2014-09-15 12:28:06

DUBLIN, Sept. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 presents comprehensive data on paracetamol (acetaminophen) markets globally and regionally (Europe, Asia, North America etc.) The report includes paracetamol (acetaminophen)...

2014-09-09 08:30:47

AT-003 Demonstrates Greater Pain Control Over Time Compared to Placebo in Client-Owned Dogs KANSAS CITY, Kan., Sept. 9, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today announced positive results from its pilot field study of its Bupivacaine Extended-Release Injectable Suspension (AT-003) for managing post-operative pain in...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...

2014-09-08 08:30:58

Studies to Investigate Ability of KP201 to Deter Abuse and Reduce Opioid-Induced Constipation CORALVILLE, Iowa, Sept. 8, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the initiation of clinical trials of KP201 designed to investigate the drug candidate's ability to deter abuse and reduce opioid-induced constipation. KP201 (benzhydrocodone hydrochloride...

2014-09-01 23:03:17

The Firm is actively evaluating Tylenol lawsuits on behalf of individuals who allegedly sustained liver damage due to acetaminophen contained in over-the-counter Tylenol products. (PRWEB) September 01, 2014 Parties involved in federally-filed Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) are looking ahead to the litigation’s status conference in September, where issues related to claims involving the pain reliever will be discussed in the Eastern District of Pennsylvania,...

2014-08-25 23:01:59

The Firm is evaluating Tylenol lawsuits on behalf of individuals who sustained severe liver damage, allegedly due to the acetaminophen in Tylenol-brand over-the-counter medications. New York, New York (PRWEB) August 25, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to mount in federal court, Bernstein Liebhard LLP notes the publication of a new analysis by Consumer Reports that raises questions about the labeling standards for over-the-counter acetaminophen...

2014-08-25 08:27:26

New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA, Aug. 25, 2014 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved ZORVOLEX® (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain. This marks the second indication...

2014-08-04 08:28:43

FREDERICK, Md., Aug. 4, 2014 /PRNewswire/ -- The following is a letter from the President of BioElectronics Corporation (OTC Pink: BIEL) to shareholders: Dear BIEL Shareholders: BioElectronics Corporation's mission is to change the way people heal and relieve their pain. As the chart below, that clearly demonstrates that, we have done exactly that. http://photos.prnewswire.com/prnvar/20140801/132705 Chronic pain sufferers in the United Kingdom said that ActiPatch reduced their pain by more...

2014-08-02 23:01:21

The Firm is evaluating Tylenol lawsuits on behalf of individuals who suffered liver damage resulting in hospitalization, liver transplantation or death, allegedly due to the acetaminophen contained in Tylenol over-the-counter medications. New York, New York (PRWEB) August 02, 2014 Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered severe liver damage due to the acetaminophen in over-the-counter Tylenol products continue to move...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'